Mpox, AIDS and COVID-19 show the challenges of targeting public health messaging to specific groups without causing stigma

Prejudice and stigma can discourage the communities most affected by infectious diseases from seeking care. Inclusive public health messaging can prevent misinformation and guide the most vulnerable.

Ken Ho, Assistant Professor of Infectious Diseases, University of Pittsburgh Health Sciences • conversation
Dec. 14, 2022 ~9 min

Kids with HIV have higher risk of neurological problems

Kids with HIV do worse in neurological tests even when their disease is controlled. Better nutrition and antiretroviral therapies may help.

Mark Michaud-Rochester • futurity
Oct. 13, 2022 ~5 min


These 4 steps could lead to detection of more STIs

A new study describes steps health care teams can take to identify and treat more sexually transmitted infections.

Andrew Smith-Rutgers • futurity
Oct. 12, 2022 ~5 min

HIV therapies currently need to be taken regularly for life – longer-lasting antibody treatments could one day offer an equally effective one-shot alternative

Antiretroviral therapies for HIV, while extremely effective, need to be taken daily for life. Designing antibody treatments that need to be taken only once could improve compliance and reduce drug resistance.

Ronald C. Desrosiers, Professor of Pathology, Vice-chair for Research, University of Miami • conversation
Sept. 23, 2022 ~7 min

HIV vaccine ingredient shows promise in primates

"This is significant progress toward a viable HIV vaccine. While we know this will be a many-step process, each step is an advancement toward our goal."

Sarah Avery-Duke • futurity
Sept. 12, 2022 ~4 min

Book reflects on ‘overlapping pandemics’

The author of a new book, "Virology," talks about HIV, COVID-19, monkeypox, and how "overlapping pandemics" shape our lives.

Rachel Harrison-NYU • futurity
Sept. 8, 2022 ~13 min

New combo therapies could stop HIV from escaping

Carefully designed cocktails of antibodies could help treat HIV while reducing the chance that it evolves to "escape" treatment, researchers say.

U. Washington • futurity
July 25, 2022 ~6 min

HIV drug stabilizes progression in metastatic colorectal cancer

A drug widely used in HIV therapy has shown to stop disease progression in 25 percent of patients with fourth-line metastatic colorectal cancer.

Alice McCarthy • harvard
April 4, 2022 ~5 min


Closing syringe programs will lead to more HIV infections

"...shutting down syringe services programs has immediate and detrimental impacts on people who use drugs and the broader community."

Corrie Pikul-Brown • futurity
Feb. 28, 2022 ~7 min

New view of HIV sheds light on how it hides

New details about the structure of the HIV virus may help in the design and development of a vaccine that can protect against AIDS.

Jake Ellison-U. Washington • futurity
Feb. 21, 2022 ~6 min

/

8